APA

Apte R. N., Dvorkin T., Song X., Fima E., Krelin Y., Yulevitch A., Gurfinkel R., Werman A., White R. M., Argov S., Shendler Y., Bjorkdahl O., Dohlsten M., Zoller M., Segal S. & Voronov E. (20001016). Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness. : Advances in experimental medicine and biology.

Chicago

Apte R N, Dvorkin T, Song X, Fima E, Krelin Y, Yulevitch A, Gurfinkel R, Werman A, White R M, Argov S, Shendler Y, Bjorkdahl O, Dohlsten M, Zoller M, Segal S and Voronov E. 20001016. Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness. : Advances in experimental medicine and biology.

Harvard

Apte R. N., Dvorkin T., Song X., Fima E., Krelin Y., Yulevitch A., Gurfinkel R., Werman A., White R. M., Argov S., Shendler Y., Bjorkdahl O., Dohlsten M., Zoller M., Segal S. and Voronov E. (20001016). Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness. : Advances in experimental medicine and biology.

MLA

Apte R N, Dvorkin T, Song X, Fima E, Krelin Y, Yulevitch A, Gurfinkel R, Werman A, White R M, Argov S, Shendler Y, Bjorkdahl O, Dohlsten M, Zoller M, Segal S and Voronov E. Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness. : Advances in experimental medicine and biology. 20001016.